DUPILUMAB

Tips and Tricks for Diagnosing & Managing Atopic Dermatitis (AD)
155311553115531atopic dermatitisAtopic dermatitis is a heterogeneous, chronic inflammatory disease that affects upwards of 10% of children and 7% of adults in the United States. Despite being an incredibly common skin concern among patients, AD continues to pose diagnostic and treatment challenges to dermatologists. What are some common misconceptions about AD? AD always starts in childhood. FALSE. 25% of adults w …
atopic dermatitis
JDD Issue Highlights | March 2022
151531515315153The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de …
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab
149451494514945Chromate-Induced Allergic Contact Dermatitis Treated With DupilumabChromate causes persistent, difficult to treat irritant and allergic contact dermatitis in cement-handling occupational workers. When therapeutics such as topical corticosteroids, topical calcineurin inhibitors, phototherapy and immune-modulating treatments like methotrexate fail, many patients are advised that avoidance may be the only remaining option – an option that may be particularly chall …
Chromate-Induced Allergic Contact Dermatitis Treated With Dupilumab
JDD Issue Highlights | February 2022
148041480414804psoriasisThe February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk: Early Response is Associ …
psoriasis
JDD Issue Highlights | December 2021
144611446114461JDDAs 2021 draws to a close, the  Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everyt …
JDD